Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Creating a Formula for Precise, Effective Literature Searching

Posted on July 31st, 2017 by in Pharmacovigilance

Even those who are old enough to remember the days before the internet might find it hard to imagine living our lives now without access to digital information tools. People working in pharmacovigilance today may actually shudder at the thought of having to do their jobs without biomedical research solutions. Continue reading “Creating a Formula for Precise, Effective Literature Searching” »

An Update from Myelo: Expanding Our Team and Evaluating Data

Posted on December 14th, 2016 by in Pharma R&D

The focus of our current non-clinical research at Myelo Therapeutics is to fully elucidate the mode of action for prevention of myelosuppression as well as Myelo001โ€™s antiviral capabilities. But to achieve this goal, itโ€™s important to have highly skilled and motivated personnel within your team. Continue reading “An Update from Myelo: Expanding Our Team and Evaluating Data” »

Elsevier and Illumina: A meeting of mind and spirit

Posted on August 22nd, 2016 by in Pharma R&D

One of the strongest arguments for using the molecular biology modeling tool Pathway Studio is the rich content underlying its knowledge database. This was driven home recently in a conversation with the DNA/RNA sequencing company Illumina. Continue reading “Elsevier and Illumina: A meeting of mind and spirit” »

Where and How to Find Co-Occurrences in Disease Biology Research

Posted on July 29th, 2016 by in Chemistry

In research, a co-occurrence refers to two linked concepts appearing within one sentence. In disease biology, a good example would be a sentence with facts that link a protein to a disease, biological functions or other proteins. Continue reading “Where and How to Find Co-Occurrences in Disease Biology Research” »